Ask The Experts on 5 December 2016, Dublin

* Clinical Trials in ALS/MND: Where Are We Now?
Dr. Jeremy Shefner, MD, PhD
Kemper and Ethel Marley Professor and Chair of Neurology and Senior Vice President
of Barrow Neurological Institute
* Stem Cells: The Hope and the Hype
Dr. Jonathan Glass, MD
Professor of Neurology and Pathology at Emory University School of Medicine;
Director of the Emory ALS Clinic
* Project MinE: The New Genetics of ALS/MND
Dr. Jan H. Veldink, MD, PhD
Professor of Neurology and Neurogenetics and Head of the Human Neurogenetics

Unit at University Medical Center-­‐Utrecht


http://asktheexpert.webcastlive.co.uk/

22nd International Symposium on ALS/MND Sydney, Australia

19th Annual Meeting International Alliance of ALS/MND Associations
and 22nd International Symposium on ALS/MND Sydney, Australia
27 November - 2 December 2011

http://mndresearch.wordpress.com/

Orlando'dan...

“ALS is a disorder of oligodendroglial cells” and “Oligodendrocytes are a dominant neuronal support”.

(ALS, oligodendroglial hücrelerin bozukluğu durumudur ve Oligodendrositlerin nöron desteğinde çok önemli yeri vardır)

Prof Don Cleveland,

21 Uluslararası ALS MND Sempozyumu, Orlando